SILVER RONALD (Principal Accounting Officer) sold 8.7% of their position (24.17K shares) of IRONWOOD PHARMACEUTICALS INC on the open market
Open‑market sale worth $90.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 2/25/2026ACC: 0001193125-26-071495
Officer· Principal Accounting Officer
Since Jul 2021
-24.17K
Net shares
Net seller
$90.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
24.17K disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−11.55K
Price / share
$3.81
Trade value
$44.01K
% of position
4.2%
2/23/2026
276.81K→265.26K
Class A Common Stock
Direct
Shares
−12.62K
Price / share
$3.66
Trade value
$46.19K
% of position
4.8%
2/24/2026
265.26K→252.64K
Total
Net shares
−24.17K
Net value
-$90.21K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/23/2026 | S · Sale | −11.55K | $3.81 | $44.01K | 4.2% | 276.81K | 265.26K |
| Class A Common Stock Direct | 2/24/2026 | S · Sale | −12.62K | $3.66 | $46.19K | 4.8% | 265.26K | 252.64K |
| Total | −24.17K | -$90.21K | ||||||
Derivative Transactions0
No derivative transactions reported